These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30600480)

  • 41. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.
    Boni C; Fisicaro P; Valdatta C; Amadei B; Di Vincenzo P; Giuberti T; Laccabue D; Zerbini A; Cavalli A; Missale G; Bertoletti A; Ferrari C
    J Virol; 2007 Apr; 81(8):4215-25. PubMed ID: 17287266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.
    Tan AT; Koh S; Goh V; Bertoletti A
    J Gastroenterol Hepatol; 2008 Jun; 23(6):833-43. PubMed ID: 18565018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
    Wu D; Ning Q
    J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
    Han Q; Lan P; Zhang J; Zhang C; Tian Z
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.
    Shimizu Y
    World J Gastroenterol; 2012 May; 18(20):2443-51. PubMed ID: 22654441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
    Bertoletti A; Gehring AJ
    PLoS Pathog; 2013; 9(12):e1003784. PubMed ID: 24367255
    [No Abstract]   [Full Text] [Related]  

  • 49. Adaptive immunity in HBV infection.
    Bertoletti A; Ferrari C
    J Hepatol; 2016 Apr; 64(1 Suppl):S71-S83. PubMed ID: 27084039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.
    Michel ML; Pol S; Brechot C; Tiollais P
    Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.
    Dong J; Yang XF; Wang LX; Wei X; Wang AH; Hao CQ; Shen HJ; Huang CX; Zhang Y; Lian JQ
    Front Cell Infect Microbiol; 2017; 7():98. PubMed ID: 28401068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B immunopathogenesis and immunotherapy.
    Golsaz-Shirazi F; Shokri F
    Immunotherapy; 2016; 8(4):461-77. PubMed ID: 26973127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What once was lost, now is found: restoration of hepatitis B-specific immunity after treatment of chronic hepatitis B.
    Koziel MJ
    Hepatology; 1999 Apr; 29(4):1331-3. PubMed ID: 10094984
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
    Michel ML; Bourgine M; Fontaine H; Pol S
    Med Microbiol Immunol; 2015 Feb; 204(1):121-9. PubMed ID: 25511871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of innate immunity in the immunopathology and treatment of HBV infection.
    Maini MK; Gehring AJ
    J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
    Akbar SM; Al-Mahtab M; Khan MS
    Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.